 |
|
First human trial of antibacterial contact lens
June 29, 2006Biotechnology company Biosignal Ltd and the Institute for Eye Research have received ethics approval for the first human clinical trial of an antibacterial extended-wear contact lens.
The ASX-listed company commercialises a novel anti-bacterial technology identified by UNSW researchers at the Centre for Marine Biofouling and Bioinnovation.
The trial beginning on June 29 will compare the safety performance of an antibacterial contact lens to that of a standard contact lens.
The comparison involving ten people will evaluate eye health, lens performance on the eye and wearers' subjective responses. Biosignal will announce the trial's results to the market in July.
"Adverse events caused by microbial contamination of contact lenses are a major impediment to more convenient, extended wear of contact lenses," says UNSW Professor Mark Willcox, who will supervise the trial. "This trial is the first significant step towards overcoming this significant problem."
Acute red eye occurs in 20 percent per year of the estimated 100 million wearers of contact lenses worldwide. Microbial keratitis, a serous eye disease that can cause blindness, occurs in one in 500 contact lens wearers per year if they sleep in lenses. There is currently no antibacterial contact lens in the market.
Biosignal's technology prevents and disrupts microbial infection by "jamming" the signalling systems bacteria rely on to form biofilms. Because the technology does not kill bacteria, Biosignal's technology is less likely to create the drug-resistance problems that plague current anti-microbial treatments. The US Centers for Disease Control estimate that biofilms account for at least two-thirds of all chronic bacterial infections.
Biosignal and the Institute for Eye Research have tested antibiofilm compounds and generated proof of concept data in a broad range of product categories in the medical, industrial and consumer fields.
The University of New South Wales
The comparison involving ten people will evaluate eye health, lens performance on the eye and wearers' subjective responses. Biosignal will announce the trial's results to the market in July.
"Adverse events caused by microbial contamination of contact lenses are a major impediment to more convenient, extended wear of contact lenses," says UNSW Professor Mark Willcox, who will supervise the trial. "This trial is the first significant step towards overcoming this significant problem."
Acute red eye occurs in 20 percent per year of the estimated 100 million wearers of contact lenses worldwide. Microbial keratitis, a serous eye disease that can cause blindness, occurs in one in 500 contact lens wearers per year if they sleep in lenses. There is currently no antibacterial contact lens in the market.
Biosignal's technology prevents and disrupts microbial infection by "jamming" the signalling systems bacteria rely on to form biofilms. Because the technology does not kill bacteria, Biosignal's technology is less likely to create the drug-resistance problems that plague current anti-microbial treatments. The US Centers for Disease Control estimate that biofilms account for at least two-thirds of all chronic bacterial infections.
Biosignal and the Institute for Eye Research have tested antibiofilm compounds and generated proof of concept data in a broad range of product categories in the medical, industrial and consumer fields.
The University of New South Wales
More Antibacterial Contact Lens Current Events and Antibacterial Contact Lens News Articles
 |
The 2009-2014 Outlook for Eye and Ear Preparations and Contact Lens Solutions Excluding Anti-Infective Corticoids, Antibacterials, and Antiseptics in the United States by Icon Group International (Author) This econometric study covers the latent demand outlook for eye and ear preparations and contact lens solutions excluding anti-infective corticoids, antibacterials, and antiseptics across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 13,000 cities in the United States. For each city in question, the percent share the city is of it's state and of the United States is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-a-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state and city, latent demand estimates... |
 |
The 2007-2012 Outlook for Eye and Ear Preparations and Contact Lens Solutions Excluding Anti-Infective Corticoids, Antibacterials, and Antiseptics in Japan by Philip M. Parker (Author) This study covers the latent demand outlook for eye and ear preparations and contact lens solutions excluding anti-infective corticoids, antibacterials, and antiseptics across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,000 cities in Japan. For each city in question, the percent share the city is of it’s prefecture and of Japan is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for eye and ear... |
 |
The 2007-2012 Outlook for Eye and Ear Preparations and Contact Lens Solutions Excluding Anti-Infective Corticoids, Antibacterials, and Antiseptics in India by Philip M. Parker (Author) This study covers the latent demand outlook for eye and ear preparations and contact lens solutions excluding anti-infective corticoids, antibacterials, and antiseptics across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 5,000 cities in India. For each city in question, the percent share the city is of it’s state or union territory and of India as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state or union territory and city,... |
 |
The 2007-2012 Outlook for Eye and Ear Preparations and Contact Lens Solutions Excluding Anti-Infective Corticoids, Antibacterials, and Antiseptics in Greater China by Philip M. Parker (Author) This study covers the latent demand outlook for eye and ear preparations and contact lens solutions excluding anti-infective corticoids, antibacterials, and antiseptics across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as “regions”). Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,100 cities in Greater China. For each major city in question, the percent share the city is of the region and of Greater China is reported. Each major city is defined as an area of “economic... |
 |
The 2009-2014 Outlook for Eye and Ear Preparations and Contact Lens Solutions Excluding Anti-Infective Corticoids, Antibacterials, and Antiseptics in Greater China by Icon Group International (Author) This econometric study covers the latent demand outlook for eye and ear preparations and contact lens solutions excluding anti-infective corticoids, antibacterials, and antiseptics across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as "regions"). Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,100 cities in Greater China. For each major city in question, the percent share the city is of the region and of Greater China is reported. Each major city is defined as an area of "economic... |
 |
The 2009-2014 Outlook for Eye and Ear Preparations and Contact Lens Solutions Excluding Anti-Infective Corticoids, Antibacterials, and Antiseptics in India by Icon Group International (Author) This econometric study covers the latent demand outlook for eye and ear preparations and contact lens solutions excluding anti-infective corticoids, antibacterials, and antiseptics across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 5,100 cities in India. For each city in question, the percent share the city is of it's state or union territory and of India as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-a-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state or union territory and... |
 |
The 2009-2014 Outlook for Eye and Ear Preparations and Contact Lens Solutions Excluding Anti-Infective Corticoids, Antibacterials, and Antiseptics in Japan by Icon Group International (Author) This econometric study covers the latent demand outlook for eye and ear preparations and contact lens solutions excluding anti-infective corticoids, antibacterials, and antiseptics across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,000 cities in Japan. For each city in question, the percent share the city is of it's prefecture and of Japan is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-a-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for eye and... |
 |
The 2009-2014 World Outlook for Eye and Ear Preparations and Contact Lens Solutions Excluding Anti-Infective Corticoids, Antibacterials, and Antiseptics by Icon Group (Author) This econometric study covers the world outlook for eye and ear preparations and contact lens solutions excluding anti-infective corticoids, antibacterials, and antiseptics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the... |
 |
The 2007-2012 World Outlook for Eye and Ear Preparations and Contact Lens Solutions Excluding Anti-Infective Corticoids, Antibacterials, and Antiseptics by Philip M. Parker (Author) This study covers the world outlook for eye and ear preparations and contact lens solutions excluding anti-infective corticoids, antibacterials, and antiseptics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level.... |
 |
The 2006-2011 World Outlook for Eye and Ear Preparations and Contact Lens Solutions Excluding Anti-Infective Corticoids, Antibacterials, and Antiseptics b WHAT IS LATENT DEMAND AND THE P.I.E.? The concept of latent demand is rather subtle. The term latent typically refers to something that is dormant, not observable, or not yet realized. Demand is the notion of an economic quantity that a target population or market requires under different assumptions of price, quality, and distribution, among other factors. Latent demand, therefore, is commonly defined by economists as the industry earnings of a market when that market becomes accessible and attractive to serve by competing firms. It is a measure, therefore, of potential industry earnings (P.I.E.) or total revenues (not profit) if a market is served in an efficient manner. It is typically expressed as the total revenues potentially extracted by firms. The “market” is defined at... |
| © 2009 BrightSurf.com |